InvestorsHub Logo

lorema

01/27/17 9:23 AM

#169927 RE: Waverunner1 #169925

He is backtracking a little bit!

"Of the three drugs in the Cellceutix (CTIX) pipeline, Kevetrin is the most likely to go nowhere."

Is he saying that the other two drugs do have a chance?

robwilly

01/27/17 2:13 PM

#170015 RE: Waverunner1 #169925

This should be stickied. Don't know who wrote this,
but it sure exposes AF as a biased and unbelievable analyst.